Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cencora, Inc. Common Stock (NY:COR)

278.81 +0.72 (+0.26%)
Streaming Delayed Price Updated: 1:20 PM EDT, Apr 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cencora, Inc. Common Stock

< Previous 1 2 3 4 5 Next >
Cencora Announces Date and Time for Second Quarter Fiscal 2025 Earnings Release
From Cencora
Via Business Wire
EXCLUSIVE: AdvisorShares Portfolio Manager Says Market 'Nervous' In 2025, Encourages Investors To Have 'Long-Term Focus'
An ETF portfolio manager highlights how his fund is beating the broader market and what advice he has for investors in 2025 in an exclusive Benzinga interview. 
Via Benzinga
Topics ETFs
Health Insurance Providers Stocks Q4 Highlights: CVS Health (NYSE:CVS)
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the health insurance providers industry, including CVS Health (NYSE:CVS) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy Fraud
Exposures Artificial Intelligence Interest Rates Legal
Here's How Much You Would Have Made Owning Cencora Stock In The Last 10 Years
Via Benzinga
$100 Invested In Cencora 5 Years Ago Would Be Worth This Much Today
Via Benzinga
Earnings Scheduled For February 5, 2025
Via Benzinga
$100 Invested In Cencora 10 Years Ago Would Be Worth This Much Today
Via Benzinga
Q4 Earnings Highlights: Cencora (NYSE:COR) Vs The Rest Of The Health Insurance Providers Stocks
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the health insurance providers industry, including Cencora (NYSE:COR) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy Fraud
Exposures Artificial Intelligence Interest Rates Legal
3 Market-Beating Stocks to Target This Week
The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta year in and year out often become the legends... 
Via StockStory
What Analysts Are Saying About Cencora Stock
Via Benzinga
Q4 Earnings Outperformers: Cigna (NYSE:CI) And The Rest Of The Health Insurance Providers Stocks
Let’s dig into the relative performance of Cigna (NYSE:CI) and its peers as we unravel the now-completed Q4 health insurance providers earnings season. 
Via StockStory
Topics Artificial Intelligence Economy Fraud
Exposures Artificial Intelligence Interest Rates Legal
Which S&P500 stocks are moving on Monday?
Curious about the S&P500 stocks that are in motion on Monday? Join us as we explore the top movers within the S&P500 index during today's session. 
Via Chartmill
Q4 Earnings Highlights: UnitedHealth (NYSE:UNH) Vs The Rest Of The Health Insurance Providers Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at UnitedHealth (NYSE:UNH) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy Fraud
Exposures Artificial Intelligence Interest Rates Legal
2 Large-Cap Stocks with Exciting Potential and 1 to Avoid
Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth... 
Via StockStory
Topics Intellectual Property
Exposures Intellectual Property
Health Insurance Providers Q4 Earnings: Progyny (NASDAQ:PGNY) Simply the Best
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the health insurance providers stocks, including Progyny (NASDAQ:PGNY) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy Fraud
Exposures Artificial Intelligence Interest Rates Legal
What To Expect From Alignment Healthcare’s (ALHC) Q4 Earnings
Health insurance company Alignment Healthcare (NASDAQ:ALHC) will be reporting earnings tomorrow after market hours. Here’s what to look for. 
Via StockStory
What To Expect From Progyny’s (PGNY) Q4 Earnings
Fertility benefits company Progyny (NASDAQ:PGNY) will be announcing earnings results tomorrow after market close. Here’s what investors should know. 
Via StockStory
What To Expect From Clover Health’s (CLOV) Q4 Earnings
Health insurance company Clover Health (NASDAQ:CLOV) will be reporting results tomorrow afternoon. Here’s what to look for. 
Via StockStory
1 Healthcare Stock to Hold Forever and 2 to Ignore
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the... 
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
The Ultimate Guide To Stock Investing Success
A discussion about how you can really identify stocks that you can add to your portfolio that will be winners in the long run. 
Via Talk Markets
Topics Stocks / Equities
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Humana Earnings On Deck: Investors Brace For Slower Growth Clip
Humana to release Q4 2024 earnings on Feb. 11 before market hours. Previous quarter saw 15.2% revenue increase, EPS beat but missed guidance. 
Via Benzinga
Humana (HUM) Q4 Earnings: What To Expect
Health insurance company Humana (NYSE:HUM) will be reporting results tomorrow before market hours. Here’s what to expect. 
Via StockStory
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.
Let's take a closer look at the S&P500 stocks with an unusual volume in today's session on Friday. Stay informed about the market activity below. 
Via Chartmill
Walgreens Cashes In: Slashes Cencora Stake Again In Debt-Fighting Move
Walgreens Boots Alliance further reduced stake in Cencora. Walgreens reports early settlement of certain prepaid variable share forward transactions with respect to shares of Cencora for delivery of an... 
Via Benzinga
Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
From Cencora
Via Business Wire
Cencora Q1 Earnings: Revenue And EPS Beat On Strong Push From Obesity Drugs, Specialty Medicines
Cencora posted Q1 sales of $81.5 billion, exceeding forecasts, with strong GLP-1 drug sales. Adjusted EPS beat estimates, and FY25 guidance was raised. 
Via Benzinga
Cencora (NYSE:COR) Reports Upbeat Q4
Healthcare distributor Cencora (NYSE:COR) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 12.8% year on year to $81.49 billion. Its non-GAAP profit of $3.73 per... 
Via StockStory
Cencora Reports Fiscal 2025 First Quarter Results
From Cencora
Via Business Wire
Stocks Rebound, Google Eyes Worst Drop In A Year, Gold Shatters Fresh Records: What's Driving Markets Wednesday?
Wall Street rose on Wednesday, with all major equity indices advancing as investors assessed the latest batch of corporate earnings and drew optimism from positive labor market data. 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.